EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Equine bone marrow aspirate and bone marrow aspirate concentrate are enriched with interleukin-1 receptor antagonist protein

Sidney Long, Grigorios Maleas, Zarah A Belacic, Vivian G Quam, Sushmitha Durgam

American Journal of Veterinary Research · 01.05.2025 · 86 (5)

DOI: 10.2460/ajvr.24.12.0380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.05.2025. Verfasst von Sidney Long und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Bone Marrow, Bone Marrow Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To analyze the cellular, growth factor, and cytokine composition of equine sternal bone marrow aspirate (BMA) and laboratory-centrifuged BMA concentrate (BMAC).

Methods

This was an in vitro experimental study. Cellular composition, growth factors (IGF-I, VEGF, PDGF, TGF-β1), and cytokines (IL-6, IL-10, tumor necrosis factor-α (TNF-α), and IL-1 receptor antagonist protein [IL-1Ra]) were quantified using a standard automated hematology analyzer and ELISA methods, respectively, in donor-matched BMA, BMAC (in-house centrifugation protocol), whole blood, and platelet-rich plasma (E-PET; Pall Inc) prepared from 25 horses from 2016 through 2020.

Results

Leukocytes, neutrophils, monocytes, lymphocytes, and thrombocytes were increased 4.1-, 3.4-, 4.6-, 4.4-, and 2.5-fold in BMAC compared to BMA, respectively. Interleukin-1 receptor antagonist protein of BMAC was increased 21-fold compared to BMA and increased 117-fold compared to gravity filtration system–based, leukocyte-rich platelet-rich plasma.

Conclusions

Laboratory centrifugation enriches the cellular and IL-1Ra concentrations of equine BMAC compared to BMA, with no significant changes in IGF-I, VEGF, PDGF, TGF-β1, IL-6, IL-10, or TNF-α concentrations. Clinical Relevance Equine BMA and BMAC are patient-side biologics enriched with anti-inflammatory IL-1Ra and support further evaluation of equine BMAC for musculoskeletal tissue healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin 1 Receptor Antagonist ProteinBone MarrowBone Marrow CellsAnimalsHorsesCytokinesMaleFemale

Stichwörter der Autor:innen

BMACIl-1RaPRPbone marrow aspiratehorse

Substanzen

Interleukin 1 Receptor Antagonist ProteinCytokines

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH.
  • Equuria GbR Equine Orthopedics, Emstek, Germany.

Förderung

  • NIH HHS

Zitieren

APA

Long, S., Maleas, G., Belacic, Z. A., Quam, V. G., & Durgam, S. (2025). Equine bone marrow aspirate and bone marrow aspirate concentrate are enriched with interleukin-1 receptor antagonist protein. American Journal of Veterinary Research, 86(5). https://doi.org/10.2460/ajvr.24.12.0380

Vancouver

Long S, Maleas G, Belacic ZA, Quam VG, Durgam S. Equine bone marrow aspirate and bone marrow aspirate concentrate are enriched with interleukin-1 receptor antagonist protein. American Journal of Veterinary Research. 2025;86(5). doi:10.2460/ajvr.24.12.0380

BibTeX
@article{Long2025,
  author = {Long, Sidney and Maleas, Grigorios and Belacic, Zarah A and Quam, Vivian G and Durgam, Sushmitha},
  title = {Equine bone marrow aspirate and bone marrow aspirate concentrate are enriched with interleukin-1 receptor antagonist protein},
  journal = {American Journal of Veterinary Research},
  year = {2025},
  volume = {86},
  number = {5},
  doi = {10.2460/ajvr.24.12.0380}
}
Kostenlos starten →